Neurodiagnostics Market, By Product Type (Reagents & Consumables, Diagnostic & Imaging Systems, and Clinical Testing Instruments), By Application, By End Use, By Technology, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Market Research Image
Report ID AV5224
Published Date May 2026
Pages 322
Industry Healthcare
Format PPT/PDF
Base Year 2025
Historical Data 2019-2024
Delivery Timeline 24 Hour

REPORT HIGHLIGHT

Neurodiagnostics Market size was valued at US$ 9,205.8 Million in 2025, expanding at a CAGR of 7.7% from 2026 to 2033.

Neurodiagnostics refers to a wide range of medical tools and procedures used to examine the brain, spinal cord, peripheral nerves, and muscular system for the detection and monitoring of neurological disorders. It enables healthcare professionals to diagnose and track conditions such as epilepsy, stroke, Alzheimer’s disease, Parkinson’s disease, and other neurological illnesses.

Common diagnostic techniques include electroencephalography (EEG), electromyography (EMG), magnetic resonance imaging (MRI), computed tomography (CT) scans, and nerve conduction studies. According to the National Institute of Neurological Disorders and Stroke, these technologies play a critical role in monitoring brain activity and neural function in real time, supporting earlier and more accurate detection of complex neurological conditions. The World Health Organization also emphasizes that neurological disorders are a leading cause of disability worldwide, highlighting the importance of improved diagnostic access and infrastructure. In addition, the National Institutes of Health supports extensive brain research initiatives focused on advancing neuroimaging techniques and neurotechnology development to improve diagnosis and treatment outcomes.

Neurodiagnostics Market- Market Dynamics

Progress in Imaging, AI, and Digital Diagnostic Technologies

Advancements in imaging systems, artificial intelligence, and digital diagnostic technologies are driving growth in the sector by improving the speed, accuracy, and reliability of neurological assessments. Modern neurodiagnostic systems are increasingly integrated with AI, cloud computing, and advanced imaging software, enabling more precise interpretation of brain activity and neural signals. Governments are also actively promoting digital transformation in healthcare to enhance diagnostic efficiency and patient outcomes. The European Commission prioritizes AI integration in healthcare under its digital health and innovation initiatives. Similarly, the Organisation for Economic Co-operation and Development emphasizes the importance of digital transformation in healthcare systems to improve diagnostic speed, accuracy, and accessibility.

In Japan, the Ministry of Health, Labour and Welfare supports the adoption of advanced medical imaging technologies to enable earlier detection of neurological disorders. On the industry side, GE HealthCare is expanding AI-powered imaging solutions for neurological analysis and workflow optimization, while Canon Medical Systems is enhancing MRI-based diagnostic platforms with advanced visualization and automation technologies. These developments are making neurological diagnostics faster, more reliable, and more widely accessible across healthcare systems.

Neurodiagnostics Market- Segmentation Analysis:
The Global Neurodiagnostics Market is segmented on the basis of Product Type, Application, End Use, Technology, and Region.

As per product type classification, the market is segmented into three categories. Diagnostic and imaging systems play a central role, as they form the core foundation for neurological assessment and disease detection. Hospitals and specialized neurology centers increasingly rely on imaging platforms and brain monitoring systems to identify structural and functional abnormalities associated with conditions such as epilepsy, stroke, dementia, and other neurodegenerative disorders. From an industry perspective, Canon Medical Systems continues to expand its neurological imaging portfolio through advanced MRI and CT technologies designed to support precise brain analysis and improved workflow efficiency. Similarly, Nihon Kohden strengthens its neurodiagnostic presence through EEG and patient monitoring systems widely used for neurological examinations and long-term brain activity monitoring.

Based on application segmentation, the market is divided into six categories: neurodegenerative diseases, epilepsy and seizure disorders, cerebrovascular disorders, sleep disorders, headache and migraine, and neuromuscular disorders. Among these, neurodegenerative diseases account for a significant share, driven by the growing need for early detection and continuous monitoring of conditions affecting brain function and cognitive health. Diseases such as Alzheimer’s disease, Parkinson’s disease, and dementia develop progressively, making advanced neurological diagnostics essential for timely intervention and effective disease management. On the industry side, Medtronic continues to expand its neurological monitoring and brain therapy technologies that support patient evaluation and treatment pathways for neurodegenerative conditions. In addition, Roche is advancing biomarker-based neurological diagnostics and research focused on Alzheimer’s disease and related cognitive disorders through its neuroscience initiatives.

Neurodiagnostics Market- Geographical Insights
From a regional outlook perception, differences in healthcare guidelines, research funding, and clinical infrastructure suggestively effect market growth patterns across geographies. North

North America is well positioned to contribute significantly to the market due to its advanced clinical infrastructure and strong regulatory support for neurological research and diagnostic innovation. In the United States, the National Institute of Neurological Disorders and Stroke under the National Institutes of Health continues to fund large-scale brain research initiatives, including the BRAIN Initiative, which supports advanced neuroimaging, neural mapping, and AI-assisted diagnostic development. Additionally, the Centers for Disease Control and Prevention reports that neurological disorders remain a major contributor to disability and long-term care needs, further increasing demand for early and accurate diagnostic solutions. On the industry side, Medtronic actively develops neurodiagnostic and neuromodulation technologies integrated with clinical monitoring systems to improve diagnostic accuracy and treatment outcomes.

Europe also plays a key role in the market due to its structured public health systems, strong regulatory frameworks, and sustained investment in neuroscience research. The European Commission has recognized neurological disorders as a growing public health challenge under its EU brain health and research frameworks, supporting early diagnosis and digital health integration. Similarly, the World Health Organization Regional Office for Europe highlights that neurological conditions contribute significantly to long-term disability across member states, reinforcing the need for improved diagnostic pathways and early intervention strategies. Countries such as Germany, France, and the United Kingdom continue to support hospital modernization and the adoption of AI-enabled imaging through national healthcare programs.

Germany Neurodiagnostics Market- Country Insights

Within this context, Germany holds a strong position in the market due to its well-structured healthcare system, advanced hospital infrastructure, and early adoption of medical technologies. The country places significant emphasis on the accurate and timely diagnosis of neurological conditions, supported by a comprehensive public healthcare framework and specialized neurology centers. For instance, the Federal Ministry of Health promotes national digital health initiatives that encourage the use of AI-enabled diagnostic systems and the integration of electronic health records to improve efficiency in neurological care. In addition, the Robert Koch Institute reports that neurological disorders such as dementia and Parkinson’s disease represent a growing public health challenge, particularly due to the country’s aging population, thereby increasing the demand for early and accurate diagnostic solutions.

Among industry players, Siemens Healthineers, headquartered in Germany, plays a leading role in advancing MRI-based neuroimaging and AI-assisted brain analysis solutions used in hospitals globally. Similarly, Bosch Healthcare Solutions contributes to the development of connected medical technologies and digital diagnostic platforms that support neurological monitoring and clinical decision-making. Together, Germany’s strong healthcare infrastructure, innovation capabilities, and structured regulatory environment make it a key contributor to neurodiagnostic advancements.

Neurodiagnostics Market- Competitive Landscape:

Supported by the expansion of digital imaging, artificial intelligence integration, and the growing prevalence of neurological disorders, the neurodiagnostics market is shaped by a combination of established medical technology leaders and specialized diagnostic innovators. Companies such as Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Natus Medical Incorporated, and Nihon Kohden play a key role in delivering advanced imaging systems, EEG/EMG monitoring devices, and AI-enabled neurological analysis platforms. These companies provide solutions through hospitals, diagnostic networks, direct institutional partnerships, and digital healthcare platforms. They are focused on improving diagnostic speed, accuracy, and workflow efficiency by integrating cloud-based analytics and machine learning technologies into neuroimaging systems. For example, Siemens Healthineers is expanding its AI-based MRI analytics capabilities to enhance brain disorder detection, while Philips Healthcare has strengthened its neuroimaging and neuroinformatics solutions through advanced neurological monitoring systems.

Recent Developments:

  • In October 2025, EssilorLuxottica acquired RetinAI to enhance AI-supported diagnostic imaging and neurological disease monitoring solutions. The acquisition is expected to strengthen AI-driven diagnostics, improve neurological monitoring, and accelerate data-based clinical decision-making across healthcare systems.

  • In September 2025, GE HealthCare announced plans to acquire icometrix to strengthen its neurodiagnostics portfolio. The integration of the icobrain AI software with MRI systems is expected to improve brain scan interpretation and support precision diagnosis for neurological disorders such as Alzheimer’s disease and multiple sclerosis.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEURODIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Siemens Healthineers
  • GE HealthCare
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • FUJIFILM Corporation
  • Thermo Fisher Scientific Inc.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Bosch Healthcare Solutions
  • F. Hoffmann-La Roche Ltd
  • EssilorLuxottica
  • Cadwell Industries Inc.
  • Advanced Brain Monitoring Inc.
  • Lifelines Neuro Company LLC
  • BioSerenity
  • Medtronic plc
  • Philips Healthcare
  • Abbott Laboratories
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Reagents & Consumables
  • Diagnostic & Imaging Systems
  • Clinical Testing Instruments
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Neurodegenerative Diseases
  • Epilepsy & Seizure Disorders
  • Cerebrovascular Disorders
  • Sleep Disorders
  • Headache & Migraine
  • Neuromuscular Disorders
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

  • Imaging Centers
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Neuroimaging Technologies
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Nuclear Medicine Imaging (PET, SPECT)
    • Near infrared spectroscopic imaging (NIRS)
    • Voxel based morphometry (VBM)
  • Neurophysiology Technologies
    • Electroencephalography (EEG)
    • Magnetoencephalography (MEG)
    • Electromyography (EMG)
    • Nerve Conduction Studies (NCS)
  • Neuroinformatics
  • In Vitro Diagnostics
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Neurodiagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Neurodiagnostics Market Snippet by Product Type
2.1.2. Neurodiagnostics Market Snippet by Application
2.1.3. Neurodiagnostics Market Snippet by End Use
2.1.4. Neurodiagnostics Market Snippet by Technology
2.1.5. Neurodiagnostics Market Snippet by Country
2.1.6. Neurodiagnostics Market Snippet by Region
2.2. Competitive Insights
3. Neurodiagnostics Key Market Trends
3.1. Neurodiagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Neurodiagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Neurodiagnostics Market Opportunities
3.4. Neurodiagnostics Market Future Trends
4. Neurodiagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Neurodiagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Neurodiagnostics Market Landscape
6.1. Neurodiagnostics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Neurodiagnostics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Reagents & Consumables
7.1.3. Diagnostic & Imaging Systems
7.1.4. Clinical Testing Instruments
7.1.5. Others
8. Neurodiagnostics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Neurodegenerative Diseases
8.1.3. Epilepsy & Seizure Disorders
8.1.4. Cerebrovascular Disorders
8.1.5. Sleep Disorders
8.1.6. Headache & Migraine
8.1.7. Neuromuscular Disorders
8.1.8. Others
9. Neurodiagnostics Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
9.1.2. Imaging Centers
9.1.3. Hospitals & Clinics
9.1.4. Diagnostic Laboratories
9.1.5. Academic & Research Institutes
9.1.6. Others
10. Neurodiagnostics Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
10.1.2. Neuroimaging Technologies
10.1.2.1. MRI
10.1.2.2. CT
10.1.2.3. PET, SPECT
10.1.2.4. NIRS
10.1.2.5. VBM
10.1.3. Neurophysiology Technologies
10.1.3.1. EEG
10.1.3.2. MEG
10.1.3.3. EMG
10.1.3.4. NCS
10.1.4. Neuroinformatics
10.1.5. In Vitro Diagnostics
10.1.6. Others
11. Neurodiagnostics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Neurodiagnostics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Neurodiagnostics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Neurodiagnostics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Neurodiagnostics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Neurodiagnostics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Neurodiagnostics Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Siemens Healthineers
12.2.2. GE HealthCare
12.2.3. Koninklijke Philips N.V.
12.2.4. Canon Medical Systems Corporation
12.2.5. FUJIFILM Corporation
12.2.6. Thermo Fisher Scientific Inc.
12.2.7. Natus Medical Incorporated
12.2.8. Nihon Kohden Corporation
12.2.9. Bosch Healthcare Solutions
12.2.10. F. Hoffmann-La Roche Ltd
12.2.11. EssilorLuxottica
12.2.12. Cadwell Industries Inc.
12.2.13. Advanced Brain Monitoring Inc.
12.2.14. Lifelines Neuro Company LLC
12.2.15. BioSerenity
12.2.16. Medtronic plc
12.2.17. Philips Healthcare
12.2.18. Abbott Laboratories
12.2.19. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEURODIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Siemens Healthineers
  • GE HealthCare
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • FUJIFILM Corporation
  • Thermo Fisher Scientific Inc.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Bosch Healthcare Solutions
  • F. Hoffmann-La Roche Ltd
  • EssilorLuxottica
  • Cadwell Industries Inc.
  • Advanced Brain Monitoring Inc.
  • Lifelines Neuro Company LLC
  • BioSerenity
  • Medtronic plc
  • Philips Healthcare
  • Abbott Laboratories
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Reagents & Consumables
  • Diagnostic & Imaging Systems
  • Clinical Testing Instruments
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Neurodegenerative Diseases
  • Epilepsy & Seizure Disorders
  • Cerebrovascular Disorders
  • Sleep Disorders
  • Headache & Migraine
  • Neuromuscular Disorders
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

  • Imaging Centers
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Neuroimaging Technologies
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Nuclear Medicine Imaging (PET, SPECT)
    • Near infrared spectroscopic imaging (NIRS)
    • Voxel based morphometry (VBM)
  • Neurophysiology Technologies
    • Electroencephalography (EEG)
    • Magnetoencephalography (MEG)
    • Electromyography (EMG)
    • Nerve Conduction Studies (NCS)
  • Neuroinformatics
  • In Vitro Diagnostics
  • Others

GLOBAL NEURODIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Choose License Type

assit assit
Related Reports

Credibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

ISO Certification ISO 9001:2015
ESOMAR Individual ESOMAR Corporate
GDPR Compliance GDPR Compliance
D-U-N-S Registered D-U-N-S Registered
BBB Accreditation BBB Accreditation
MRS MRS
CONTACT INFORMATION

U.S. Office

11923 NE Sumner St STE 750924
Portland, Oregon, 97220, USA

Asia Pacific Office

4, Rohan Business Centre, Paud Road,
Kothrud, Pune Maharashtra, 411038, India

Secure Payment By
PayPal
Visa
MasterCard
American Express
Support Hours

We’re here to assist you around the clock, six days a week.

Monday – Friday: 10:00 AM to 6:00 PM

Saturday: 10:00 AM to 3:00 PM

Sunday: Closed

© Copyright 2026 Analystview Market Insights | All Rights Reserved